Cargando…

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer

BACKGROUND: β-catenin is the key protein in the WNT signalling pathway and it forms adherent junctions together with E-cadherin. In ovarian carcinoma, abnormal expression of β-catenin, E-cadherin and WNT-1 was observed, but their prognostic and predictive role is unclear. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bodnar, Lubomir, Stanczak, Aleksandra, Cierniak, Szczepan, Smoter, Marta, Cichowicz, Marzena, Kozlowski, Wojciech, Szczylik, Cezary, Wieczorek, Maciej, Lamparska-Przybysz, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926861/ https://www.ncbi.nlm.nih.gov/pubmed/24499657 http://dx.doi.org/10.1186/1757-2215-7-16

Ejemplares similares

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
por: Stanczak, Aleksandra, et al.
Publicado: (2011)

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)

The role of Tau protein in resistance to paclitaxel
por: Smoter, Marta, et al.
Publicado: (2011)

Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
por: Grygielewicz, Paulina, et al.
Publicado: (2014)

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
por: Synowiec, Agnieszka, et al.
Publicado: (2016)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
por: Zdzalik, Daria, et al.
Publicado: (2014)

Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives
por: Stypik, Mariola, et al.
Publicado: (2022)

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
por: Klemba, Aleksandra, et al.
Publicado: (2018)

Delay in Diagnosis of Autoimmune Polyendocrine Syndrome Type 2 as a Consequence of Misinterpretation of Gastrointestinal Symptoms
por: Gonciarz, Maciej, et al.
Publicado: (2022)

Selected Immunohistochemical Assessment and Clinical Examinations in the Diagnosis of Palatine Tonsil Diseases
por: Bant, Przemysław, et al.
Publicado: (2023)

Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis
por: Gąsowska-Bajger, Beata, et al.
Publicado: (2021)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

Usefulness of 3D sonography of the central nervous system in neonates and infants in the assessment of intracranial bleeding and its consequences when examined through the anterior fontanelle
por: Zielonka-Lamparska, Edyta, et al.
Publicado: (2013)

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy
por: Sigorski, Dawid, et al.
Publicado: (2020)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
por: Slupski, Maciej W, et al.
Publicado: (2007)

Minimally invasive transnasal approach for primary ectopic meningioma of the paranasal sinuses
por: Szczygielski, Kornel, et al.
Publicado: (2015)

Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
por: Nguyen, Vu Hong Loan, et al.
Publicado: (2019)

CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway
por: Lu, Qi, et al.
Publicado: (2020)

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway
por: Cai, Yanlin, et al.
Publicado: (2021)

Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2020)

Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer
por: Stec, Rafał, et al.
Publicado: (2019)

Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca(2+) pathways in cisplatin-induced chemoresistance in ovarian cancer
por: Huang, Lu, et al.
Publicado: (2016)

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
por: Nagaraj, Anil Belur, et al.
Publicado: (2015)

Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/β-catenin pathway
por: Sun, Mei, et al.
Publicado: (2021)

Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2022)

Effect of Different Wavelengths of Laser Irradiation on the Skin Cells
por: Cios, Aleksandra, et al.
Publicado: (2021)

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
por: Solarek, Wojciech, et al.
Publicado: (2019)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Low-Grade Ovarian Stromal Tumors with Genetic Alterations of the Wnt/β-Catenin Pathway That Is Crucial in Ovarian Follicle Development and Regulation
por: Zhang, Gloria, et al.
Publicado: (2022)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
por: Sigorski, Dawid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ne83bkcuimoti9b42p0as462vr